By contrast to traditional batch methods of production, where medications are produced one step at a time, Sipat makes continuous production possible while incorporating constant quality control.
This method of production makes it possible to save up to 20 percent on costs and to cut production time from up to two months down to about ten days. Siemens will present the new version of Sipat at Achema, the world's largest chemical industry trade fair, which will be held in Frankfurt from June 18 to 22, 2012.
Manufacturing pharmaceuticals by means of batch production methods is time consuming, cost intensive, and uses a lot of energy. One batch or "charge" of products, such as tablets or capsules, moves through the production process as a unit. The raw material must be granulated, dried, pulverized, mixed, and pressed.
The process is repeatedly halted between steps so that samples can be taken. Only when it is certain that the product is completely homogenized or the active ingredient concentration has the necessary quality is the production process continued. As a result, production can take several weeks.
If the quality of the preliminary product is not up to standard, the charge is discarded. This manufacturing technique also does not make optimal use of the production facilities.
A continuous production process is less expensive, more efficient, and uses less raw materials and energy. The automation experts at Siemens have developed the Sipat software in collaboration with large pharmaceutical companies and plant manufacturers. It is the core of a continuous production system. Sipat continuously polls process data for information about moisture content, temperature, density or grain size distribution, etc.
By correlating this information, Sipat can predict the quality of any given tablet at any point in the process. If the data from the running production threatens to exceed tolerance limits, the process can be immediately adjusted. This real-time release makes it possible to achieve a production time of about ten days.
Apart from that, continuous production makes it possible to use production facilities much more efficiently. Plant manufacturers can simply integrate the newest version V4 of Sipat into their systems.
Dr. Norbert Aschenbrenner | Siemens InnovationNews
Biophysicists reveal how optogenetic tool works
29.05.2020 | Moscow Institute of Physics and Technology
Mapping immune cells in brain tumors
29.05.2020 | University of Zurich
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.
When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...
Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.
Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...
Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.
A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
29.05.2020 | Materials Sciences
29.05.2020 | Materials Sciences
29.05.2020 | Power and Electrical Engineering